Corporate
Description
  • Value proposition

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

    Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

  • Original language

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

  • Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

    Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

  • https://www.kurmapartners.com/en
Entity interactions BETA
Entity TypeTweets Articles
In Extenso Innovation Croissance In Extenso Innovation Croissance
consulting
Other

9 Jun 2023


SISTA SISTA
Civic and Social Organizations, fintech
Other

4 Feb 2025


Hopia Hopia
Hospitals and Health Care, healthtech
Other

28 Jan 2025


Coave Therapeutics Coave Therapeutics
Biotechnology Research, healthtech, biotech, deeptech
Other

10 Jan 2025


First Bridge Ventures First Bridge Ventures
it services
Other

16 Apr 2024


Vitale Performance Santé Vitale Performance Santé
healthtech
Other

30 Nov 2024


VIVES Partners VIVES Partners
Other

16 Jan 2025


Majycc Innovation Santé - UI Investissement Majycc Innovation Santé - UI Investissement
healthtech
Other

31 Jan 2022


HCVC HCVC
Venture Capital and Private Equity Principals
Other

7 Dec 2024


Alven Alven
Venture Capital and Private Equity Principals
Other

7 Dec 2024


Radars
Loading...